secwatch.observer — SEC 8-K summary
======================================

Issuer:     Profound Medical Corp. (PROF)
CIK:        0001628808
Form:       8-K
Filed at:   2026-02-12T23:59:59+00:00
Accession:  0001171843-26-000772
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Profound Medical receives Mount Logan Award; touts 4,000th TULSA case, new US codes, direct sales expansion
--------------------------------------------------------------------------------

- INOVAIT honored Profound with the 2025-2026 Mount Logan Award for TULSA Procedure commercialization.
- Company treated 4,000th TULSA patient and secured new Medicare reimbursement codes in the US.
- Regained exclusive Canadian distribution rights; deploying direct sales team in North America.
- Sunnybrook Health Sciences Centre performed over 100 TULSA procedures despite no provincial insurance coverage.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628808/000117184326000772/0001171843-26-000772-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628808/000117184326000772/f8k_021226.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-000772

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer